Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523687 · ClinicalTrials.gov registry record · Phase 1
AME Study of [14C]-PC14586 in Healthy Male Participants
A Phase 1 study of Healthy Male Volunteers, sponsored by PMV Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05523687 is a Phase 1 study of Healthy Male Volunteers that has completed, run by PMV Pharmaceuticals. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05523687, a Phase 1 study of Healthy Male Volunteers, has completed, sponsored by PMV Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the PK and rates of elimination and mass balance of total radioactivity from \[14C\]-PC14586
Conditions Studied
Interventions
- DRUG [14C]-PC14586
Study Locations (1)
Wisconsin
- Labcorp Clinical Research Unit Inc. - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2022-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05523687
The ClinicalTrials.gov registry entry for NCT05523687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PMV Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Male Volunteers appearing as the primary indexed condition, and to 1 intervention - of which [14C]-PC14586 is the first listed.
NCT05523687 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05523687 about?
NCT05523687 is a clinical study titled "AME Study of [14C]-PC14586 in Healthy Male Participants". This study will assess the PK and rates of elimination and mass balance of total radioactivity from \[14C\]-PC14586
What is the current status of trial NCT05523687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2022-09-06. Estimated completion is 2022-11-30.
What conditions does trial NCT05523687 study?
This clinical trial studies the following conditions: Healthy Male Volunteers.
What interventions are being tested in trial NCT05523687?
The interventions under investigation include: [14C]-PC14586 (DRUG).
Who is sponsoring clinical trial NCT05523687?
This trial is sponsored by PMV Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05523687 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Male Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.